Multiple sclerosis: TNFRSF1A, TRAPS and multiple sclerosis

Nature Reviews Neurology

Volumn 5, Issue 10, 2009, Pages 528-529

  Kümpfel, Tania ^a   Hohlfeld, Reinhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY 1A; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CEREBROSPINAL FLUID; DISEASE ACTIVITY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIPLE SCLEROSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349731730     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.154     Document Type: Article

References (9)

1. Oksenberg, J. R., Baranzini, S. E., Sawcer, S. & Hauser, S. L. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 7, 516-526 (2008).
2. De Jager, P. L. et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41, 776-782 (2009).
3. Baranzini, S. E. et al. Pathway and network-based analysis of genomewide association studies in multiple sclerosis. Hum. Mol. Genet. 18, 2078-2090 (2009).
4. Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953-1971 (2006).
5. Spuler, S. et al. Multiple sclerosis: Prospective analysis of TNF-α and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J. Neuroimmunol. 66, 57-64 (1996).
6. [No authors listed] TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study. Neurology 53, 444-445 (1999).
7. Masters, S. L., Simon, A., Aksentijevich, I. & Kastner, D. L. Horror autoinflammaticus: The molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27, 621-668 (2009).
8. Kümpfel, T. et al. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation. Arthritis Rheum. 56 2774-2783 (2007).
9. Kümpfel, T. et al. Multiple sclerosis and the TNFRSF1A R92Q-mutation: Clinical characteristics of 21 cases. Neurology 71, 1812-1820 (2008).